TRPV4 and Alzheimer disease: Other studies showed that intervention with the 5-HT2A receptor or TRPV4 inhibitor significantly reduced scratching behavior in mice, suggesting that 5-HT2A and TRPV4 may be new targets for inhibiting itch symptoms in AD [92].